Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXSAR: Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis
NCT01920919Phase 3Unknown
- Start
- Jun 2013
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in pulmonary sarcoidosis. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT01920919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920919.